Nalaganje...
Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars
Colorectal cancer (CRC) is a leading cause of tumor-related morbidity and mortality worldwide, with mortality most often attributable to metastatic disease. Bevacizumab, a humanized monoclonal antibody targeting vascular endothelial growth factor, has a significant role in the treatment of metastati...
Shranjeno v:
| izdano v: | Target Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer International Publishing
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5610666/ https://ncbi.nlm.nih.gov/pubmed/28801849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-017-0518-1 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|